Search

Stefan Keslacy

from Alhambra, CA
Age ~48
Get Report
Also known as:
Elacy L Stefan
Related to:
Thyna Keslacy, 48
Connected to:
Allen R Keslar, 53Clifford E Keslar, 74Letha M Keslar, 47Melissa Keslar, 34Becky G Kesler, 59Brenda S Kesler, 61Charli E Kesler, 33Christina Kesler, 78Clayton L Kesler, 33Gilles P Kesler, 67

Stefan Keslacy Phones & Addresses

  • Alhambra, CA
  • Los Angeles, CA
  • Jamesville, NY
  • Syracuse, NY
  • 339 9Th St, Philadelphia, PA 19107
  • 834 Chestnut St, Philadelphia, PA 19107
  • Phila, PA
  • 5862 Quarter Moon Dr, Jamesville, NY 13078

Resumes

Resumes

Stefan Keslacy Photo 1

Assistant Professor

View page
Location:
Los Angeles, CA
Industry:
Higher Education
Work:
California State University, Los Angeles
Assistant Professor
Syracuse University Sep 2007 - May 2014
Assistant Professor
Penn Medicine, University of Pennsylvania Health System May 2005 - Aug 2007
Postdoctoral Researcher
Education:
Thomas Jefferson University Hospitals 2007 - 2008
Skills:
Higher Education
University Teaching
Grant Writing
Molecular Biology
Research
Science
Judo
Research Design
Academic Advising
Statistics
Teaching
Lecturing
Life Sciences
Program Evaluation
Public Speaking
Microsoft Office
Powerpoint
Biochemistry
Stefan Keslacy Photo 2

Stefan Keslacy

View page

Publications

Us Patents

System And Method For Identifying And Applying Peripheral Treatment Mechanisms For Disease

View page
US Patent:
20120172417, Jul 5, 2012
Filed:
Sep 21, 2011
Appl. No.:
13/238647
Inventors:
Stefan Keslacy - Syracuse NY, US
Assignee:
SYRACUSE UNIVERSITY - Syracuse NY
International Classification:
A61K 31/7088
C40B 30/00
A61P 25/00
A61P 25/28
A61P 3/04
A61P 3/10
US Classification:
514 44 R, 506 7
Abstract:
A method and system for the identification and application of biological targets for peripheral treatment of diseases. Existing cellular mechanisms or pathways are exploited to identify novel genes or other molecule candidates that will be used to treat disease via a peripheral treatment system. Using the method, a novel Alzheimer's disease target is identified and used to treat an animal Alzheimer's disease model via peripheral expression of that target.
Control profile
Stefan Keslacy from Alhambra, CA, age ~48 Get Report